TrialArteriosclerosis, thrombosis, and vascular biology2018

CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.

Andreas Gille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.